A Study of Experimental Pamrevlumab in Patients With Idiopathic Pulmonary Fibrosis
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis, IPF, Idiopathic Interstitial Pneumonia, Interstitial Lung Disease, Lung Fibrosis Pulmonary Fibrosis Fibrosis Pamrevlumab
Lead Scientist at UC Davis
- Timothy Albertson
Professor, Pulmonary, Critical Care, and Sleep Medicine. Authored (or co-authored) 298 research publications.